Последние добавленные видео:
Tki
-
6 years ago
98870 6 years ago 4:20Tyrosine Kinase Inhibitors (TKIs) - Imatinib (Gleevec) - Pharmacology - CML and ALL
-
7 years ago
6129 7 years ago 4:44Mechanisms of TKI resistance
-
6 months ago
46 6 months ago 1:03SOHO-02: BAY 2927088, an oral HER2 TKI, for first-line NSCLC
-
2 years ago
251 2 years ago 2:45Understanding the cause of TKI resistance to improve management strategies in CML
-
8 years ago
143 8 years ago 1:54Dr. Figlin on TKI Therapy Options in Renal Cell Carcinoma
-
1 year ago
173 1 year ago 1:39Cost-benefit considerations for TKI selection in CML
-
7 years ago
233 7 years ago 7:14Proactive Management of TKI Side Effects in HCC
-
17 hours ago
394 17 hours ago 33:00TRAGIS & MENGERIKAN‼️TKI BAHKAN HARUS TEWAS DISANA..!? ORGAN MANUSIA DI PERJUAL BELIKAN..(TPPO)
-
3 years ago
32 3 years ago 1:45Real-world outcomes of mRCC in the current IO & TKI era
-
1 year ago
110 1 year ago 1:27The role of monotherapy TKI’s in the treatment of patients with hepatocellular carcinoma
-
8 years ago
629 8 years ago 6:57TKI Therapy for Advanced Thyroid Cancer
-
7 years ago
429 7 years ago 9:52Factors in Selecting Immunotherapy or TKI Inhibition
-
2 years ago
99 2 years ago 4:52ALK TKI Side Effects and Acquired Resistance - 2022 Program: Targeted Therapies Forum
-
2 years ago
149 2 years ago 1:42Managing cardiovascular risks associated with lifelong TKI therapy in CML
-
7 years ago
354 7 years ago 3:12EGFR-TKI Therapy in Advanced NSCLC
-
4 weeks ago
14 4 weeks ago 1:52Factors affecting adherence to TKI therapy in patients with CML
-
7 years ago
52 7 years ago 1:43Clinical Rationale for TKI Choice in mRCC
-
6 years ago
195 6 years ago 7:35Checkpoint Inhibitors Versus TKI Therapy in HCC
-
5 months ago
86 5 months ago 2:56Dr Singer on the Efficacy of IO/TKI Doublets in Advanced RCC
-
4 years ago
206 4 years ago 5:01VEGF TKI Therapy After I/O in mRCC